ArticleJournal for immunotherapy of cancer2024

Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma.

Jessica S W Borgers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.